会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • FORMULATIONS CONTAINING AN IMMUNE RESPONSE MODIFIER
    • 含有免疫反应调节剂的配方
    • WO2005016275A2
    • 2005-02-24
    • PCT/US2004/025277
    • 2004-08-05
    • 3M INNOVATIVE PROPERTIES COMPANYHAMMERBECK, David, M.GUY, Cynthia, A.LEUNG, Suzanne, S.
    • HAMMERBECK, David, M.GUY, Cynthia, A.LEUNG, Suzanne, S.
    • A61K
    • A61K31/437
    • Pharmaceutical formulations in an aqueous (preferably, sprayable) formulaiton including an immune response modifier (IRM), such as those chosen from imidazoquinoline amines, tetrahydroimidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, 1,2-bridged imidazoquinoline amines, imidazonaphthyridine amines, imidazotetrahydronaphthyridine amines, oxazoloquinoline amines, thiazoloquinoline amines, oxazolopyridine amines, thiazolopyridine amines, oxazolonaphthyridine amines, thiazolonaphthyridine amines, and 1 H -imidazo dimers fused to pyridine amines, quinoline amines, tetrahydroquinoline amines, naphthyridine amines, or tetrahydronaphthyridine amines, are provided. In one embodiment, the aqueous formulations are advantageous for treatment and/or prevention of allergic rhinitis, viral infections, sinusitis, and asthma.
    • 包含免疫应答调节剂(IRM)的水性(优选可喷雾的)配方中的药物制剂,例如选自咪唑并喹啉胺,四氢咪唑并喹啉胺,咪唑并吡啶胺,6,7-稠合的环烷基咪唑并吡啶胺,1,2-桥连的咪唑并喹啉胺, 咪唑并噻吩胺,咪唑并四氢萘啶胺,恶唑并喹啉胺,噻唑并喹啉胺,恶唑并吡啶胺,噻唑并吡啶胺,恶唑烷萘啶胺,噻唑并萘啶胺和与吡啶胺,喹啉胺,四氢喹啉胺,萘啶胺或四氢萘啶胺稠合的1H-咪唑并二聚体 。 在一个实施方案中,水性制剂对于治疗和/或预防过敏性鼻炎,病毒感染,鼻窦炎和哮喘是有利的。